These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 400825)

  • 1. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of the fish pathogen Aeromonas salmonicida to flumequine.
    Barnes AC; Lewin CS; Hastings TS; Amyes SG
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2634-5. PubMed ID: 1810198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
    Gilis PM; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1978 Mar; 13(3):533-5. PubMed ID: 263890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the maintenance and transfer of antibiotic-resistance plasmids by quinolones].
    Uccelli V; Laporte JM; Michel-Briand Y
    C R Seances Soc Biol Fil; 1985; 179(5):696-9. PubMed ID: 2938699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the in vitro activity of flumequine on bacterial strains recently isolated in the hospital].
    Nani E; Amato G; Anzivino D; Covelli I
    Boll Ist Sieroter Milan; 1986; 65(1):14-21. PubMed ID: 3718678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
    Bertolini A; Castelli M; Genedani S; Garuti M
    Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of Escherichia coli DNA in vitro: inhibition by oxolinic acid.
    Staudenbauer WL
    Eur J Biochem; 1976 Mar; 62(3):491-7. PubMed ID: 770163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
    Gellert M; Mizuuchi K; O'Dea MH; Itoh T; Tomizawa JI
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4772-6. PubMed ID: 337300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.
    Sugino A; Peebles CL; Kreuzer KN; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4767-71. PubMed ID: 200930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial resistance to quinolone antibiotics in Poland.
    Roliński Z; Kowalski C; Zań R; Sobol M
    J Vet Med B Infect Dis Vet Public Health; 2002 Apr; 49(3):160-2. PubMed ID: 12019949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.
    Gordon RC; Stevens LI; Edmiston CE; Mohan K
    Antimicrob Agents Chemother; 1976 Dec; 10(6):918-20. PubMed ID: 12717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of bacteriophage lambda with oxolinic and nalidixic acid.
    Vihanová D; Vondrejs V
    Folia Microbiol (Praha); 1974; 19(5):390-3. PubMed ID: 4611869
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the bacterial DNA gyrase inhibitors, novobiocin, nalidixic acid, and oxolinic acid, on oxidative phosphorylation.
    Gallagher M; Weinberg R; Simpson MV
    J Biol Chem; 1986 Jul; 261(19):8604-7. PubMed ID: 3013857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
    Cantet P; Renaudin H; Quentin C; Bebear C
    Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.